Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Shimada

Showing results (311-320 of 365) with videos related to

Pageof 37
Sort By:
Medicine International|March 6, 2023
The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinomaMasaaki Ito, Satoshi Yajima, Takashi Suzuki, et al.
Molecular Cancer Research : MCR|April 13, 2012
SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expressionKazuyuki Matsushita, Toshiko Kajiwara, Mai Tamura, et al.
Scientific Reports|August 11, 2022
[S-methyl-<sup>11</sup>C]-L-methionine positron emission tomography/computed tomography imaging parameters to evaluate early response for esophageal cancer with neoadjuvant carbon ion radiotherapyKazuo Narushima, Ryuichi Nishii, Shinichi Okazumi, et al.
Cancer Science|April 18, 2024
Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinomaMasaaki Ito, Satoshi Yajima, Takashi Suzuki, et al.
International Immunology|May 19, 2005
Prolonged skin allograft survival by IL-10 gene-introduced CD4 T cell administrationTakeshi Miyamoto, Takaaki Kaneko, Masakatsu Yamashita, et al.
Molecular and Clinical Oncology|March 7, 2022
Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric CancerMasaaki Ito, Yusuke Oji, Mayuko Adachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2017
[A Case of Aortoesophageal Fistula Rupture Due to Descending Thoracic Aortic Dissection with Recurrent Colon Cancer during Chemotherapy Containing Bevacizumab]Takamaru Koda, Junichi Koike, Hiroshi Masuhara, et al.
Drug Discoveries & Therapeutics|June 14, 2026
Metabolic and endocrinological effects of weekly growth hormone replacement therapy with somapacitan in patients with adult growth hormone deficiency after switching from daily growth hormone replacement therapy: A real-world exploratory cohort studyIchiro Abe, Keita Kubo, Yuya Fujita, et al.
The Journal of Gene Medicine|December 15, 2018
Cloning of carrier cells infected with oncolytic adenovirus driven by midkine promoter and biosafety studiesKatsuyuki Hamada, Soichi Takagi, Hajime Kuboshima, et al.
International Journal of Cancer|June 24, 2020
Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter studyRei Okada, Yuichiro Otsuka, Taiga Wakabayashi, et al.
Pageof 37

Showing results (311-320 of 365) with videos related to

Sort By:
Pageof 37
Medicine International|March 6, 2023
The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinomaMasaaki Ito, Satoshi Yajima, Takashi Suzuki, et al.
Molecular Cancer Research : MCR|April 13, 2012
SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expressionKazuyuki Matsushita, Toshiko Kajiwara, Mai Tamura, et al.
Scientific Reports|August 11, 2022
[S-methyl-<sup>11</sup>C]-L-methionine positron emission tomography/computed tomography imaging parameters to evaluate early response for esophageal cancer with neoadjuvant carbon ion radiotherapyKazuo Narushima, Ryuichi Nishii, Shinichi Okazumi, et al.
Cancer Science|April 18, 2024
Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinomaMasaaki Ito, Satoshi Yajima, Takashi Suzuki, et al.
International Immunology|May 19, 2005
Prolonged skin allograft survival by IL-10 gene-introduced CD4 T cell administrationTakeshi Miyamoto, Takaaki Kaneko, Masakatsu Yamashita, et al.
Molecular and Clinical Oncology|March 7, 2022
Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric CancerMasaaki Ito, Yusuke Oji, Mayuko Adachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2017
[A Case of Aortoesophageal Fistula Rupture Due to Descending Thoracic Aortic Dissection with Recurrent Colon Cancer during Chemotherapy Containing Bevacizumab]Takamaru Koda, Junichi Koike, Hiroshi Masuhara, et al.
Drug Discoveries & Therapeutics|June 14, 2026
Metabolic and endocrinological effects of weekly growth hormone replacement therapy with somapacitan in patients with adult growth hormone deficiency after switching from daily growth hormone replacement therapy: A real-world exploratory cohort studyIchiro Abe, Keita Kubo, Yuya Fujita, et al.
The Journal of Gene Medicine|December 15, 2018
Cloning of carrier cells infected with oncolytic adenovirus driven by midkine promoter and biosafety studiesKatsuyuki Hamada, Soichi Takagi, Hajime Kuboshima, et al.
International Journal of Cancer|June 24, 2020
Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter studyRei Okada, Yuichiro Otsuka, Taiga Wakabayashi, et al.
Pageof 37